Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment)
Lymphoma, Non-Hodgkin
Janssen Research & Development, LLCmonoclonal_antibodyPhase 1Active
CC
42/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 73/ 100
Competitive context
410 Active assets in the Lymphoma, Non-Hodgkin cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CYCLOSPORIN A Memorial Sloan Kettering Cancer Center | Phase 3 | BBB |
PEGASPARGASE Ciusss de L'Est de l'Île de Montréal | Phase 4 | BBB |
Inno-206 National Cancer Institute (NCI) | Phase 4 | BBB |
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE Mwanasha Merrill, MD | Phase 3 | BBB |
Entecavir Fudan University | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
Immunoglobulin G4, anti-(human CD3 antigen) (recombinant human monoclonal JNJ-75348780 ?4-chain), disulfide with recombinant human monoclonal JNJ-75348780 ? chain, (229?126?),(232?129?)-bis(disulfide) with immunoglobulin, anti-(human sialic acid-binding Ig-like lectin 2) (recombinant human single-domain VHH fragment) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →